Jin Nakahara

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys

Yuji Nagai, Naohisa Miyakawa, Hiroyuki Takuwa et al. · Nature Neuroscience · 2020 · 399 citations

Behavioral Modulations, Behavioral Neuroscience, Medicine +13

Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice

Tomonori Kaifu, Jin Nakahara, Masanori Inui et al. · Journal of Clinical Investigation · 2003 · 347 citations · Full text

Sclerostin, Immune System, Osteoporosis +16

Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy

Yurika Watanabe, Akinori Uruha, Shigeaki Suzuki et al. · Journal of Neurology Neurosurgery & Psychiatry · 2016 · 312 citations

Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients

Shigeaki Suzuki, Atsuko Nishikawa, Masataka Kuwana et al. · Orphanet Journal of Rare Diseases · 2015 · 217 citations · Full text